Advances in Therapy

, Volume 18, Issue 4, pp 189–193 | Cite as

Preventing the common cold with a garlic supplement: A double-blind, placebo-controlled survey

  • Peter Josling
Article

Abstract

One hundred forty-six volunteers were randomized to receive a placebo or an allicin-containing garlic supplement, one capsule daily, over a 12-week period between November and February. They used a five-point scale to assess their health and recorded any common cold infections and symptoms in a daily diary. The active-treatment group had significantly fewer colds than the placebo group (24 vs 65,P < .001). The placebo group, in contrast, recorded significantly more days challenged virally (366 vs 111,P < .05) and a significantly longer duration of symptoms (5.01 vs 1.52 days,P < .001). Consequently, volunteers in the active group were less likely to get a cold and recovered faster if infected. Volunteers taking placebo were much more likely to get more than one cold over the treatment period. An allicin-containing supplement can prevent attack by the common cold virus.

Keywords

allicin common cold garlic supplement 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Eccles R. Common Cold Centre, Cardiff, UK. Available at: http://www.cf.ac.uk/biosi/ associates/cold/home.html.Google Scholar
  2. 2.
    Koch HP, Lawson LD.Garlic—The Science and Therapeutic Application of Allium Sativum L and Related Species. Baltimore: Williams & Wilkins; 1996.Google Scholar
  3. 3.
    Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic.Microbes Infect. 1999;2: 125–129.CrossRefGoogle Scholar
  4. 4.
    Hanley AB, Fenwick CR. Cultivated alliums.J Plant Foods. 1985;6:211–238.Google Scholar
  5. 5.
    Data on file. Garlic Centre, East Sussex, UK.Google Scholar

Copyright information

© Health Communications Inc 2001

Authors and Affiliations

  • Peter Josling
    • 1
  1. 1.Garlic Centre BattleEast SussexUK

Personalised recommendations